ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Luigi Liguori

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0232-1452; OpenAlex author ID A5034550263. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A Narrative Review. Co-author DOI 10.1245/s10434-025-19056-0 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marco Ventin · 1 shared paper, 2026 · strength 0.33
- Paper Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A… DOI 10.1245/s10434-025-19056-0 ↗
Giulia Cattaneo · 1 shared paper, 2026 · strength 0.33
- Paper Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A… DOI 10.1245/s10434-025-19056-0 ↗
Cristina Rosa Ferrone · 1 shared paper, 2026 · strength 0.33
- Paper Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A… DOI 10.1245/s10434-025-19056-0 ↗
Arsen Osipov · 1 shared paper, 2026 · strength 0.33
- Paper Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A… DOI 10.1245/s10434-025-19056-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.